Valuation Methodology
Sweet Value Labuses 7 valuation models to estimate intrinsic value. Every assumption is visible and inspectable. Here's how each model works.
Cost of Capital (WACC)
All DCF models discount future cash flows using the Weighted Average Cost of Capital (WACC). Our calculation:
1–2. DCF Growth Exit (5Y & 10Y)
Projects free cash flow for 5 or 10 years, then calculates a terminal value using the Gordon Growth Model.
3–4. DCF EBITDA Exit (5Y & 10Y)
Same FCF projection as above, but uses an EV/EBITDA exit multiple for the terminal value instead of perpetuity growth.
5. P/E Multiples
A relative valuation comparing the company to industry peers using Price-to-Earnings ratios.
6. EV/EBITDA Multiples
Enterprise value-based relative valuation, less affected by capital structure differences than P/E.
7. PEG Fair Value
A fairly priced stock has a P/E ratio equal to its earnings growth rate (PEG = 1.0). Includes dividend yield for the full PEGY variant.
Fair Value
The headline fair value is derived from our primary DCF model — a 5-year unlevered Free Cash Flow to Firm (FCFF) projection with a Gordon Growth terminal value. All other models (FCFF EBITDA Exit, Trading Multiples, PEG, EPV) are shown on the summary page for reference and cross-validation.
Each company is automatically classified into one of 8 archetypes (e.g., High Growth, Mature & Stable, Cyclical) based on financial metrics including revenue growth, profitability, dividend yield, and earnings volatility. The archetype determines the terminal growth rate used in all DCF models.
Data Sources
Limitations
- All models rely on historical data and analyst estimates which may not predict future performance
- DCF models are highly sensitive to WACC and terminal value assumptions
- Relative valuation depends on peer selection and may not capture company-specific factors
- Financial companies (banks, insurance) may require specialized models not yet implemented
- Beta is sourced from FMP without Blume adjustment; actual cost of equity may differ
Sweet Value Lab is for informational purposes only and does not constitute financial advice. Always do your own research before making investment decisions.